Ophthalmic composition for the treatment of ocular infection
US9789058B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 18, 2015 |
| Grant date | Oct 17, 2017 |
| Priority date | — |
| Expiry date | Jun 18, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0051
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An ophthalmic composition for administration to an eye of a patient for the treatment of an ocular infection. The ophthalmic composition contains an ε-polylysine (εPL) in an amount effective to treat or control or prevent the ocular infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.